Dr Conway received his medical degree from McGill University in 1982. After his internship and residency, he completed a fellowship in Infectious Diseases at the University of Manitoba and a fellowship in HIV medicine at Harvard University. Since that time, he has been in medical practice with a focus on HIV, HCV, and other infectious diseases. Dr. Conway's efforts in the advancement of healthcare have been awarded with the Queen Elizabeth II Diamond Jubilee Medal of Recognition for significant contribution to the field of HIV/AIDS and vulnerable populations in Canada.

Prof. Oana Săndulescu is Full Professor of Infectious Diseases at the Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, and senior specialist in Infectious Diseases and specialist in Epidemiology at the National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Romania.<br><br>She is currently Chair of the Executive Committee of the ESCMID Group for Viral Hepatitis (ESGVH), Chair of Ecraid's Clinical Liaison Council and member of the Steering Committee of EACS European Young Investigators (YING).

Dr Ward directs the Coalition for Global Hepatitis Elimination of the Task Force for Global Health providing a community of practice for partners in over 90 countries to collaborate, receive technical assistance, and operational research. Globally, Dr Ward advises hepatitis elimination activities of national governments, WHO, Africa CDC and other organizations. Over a 13 year tenure, Dr Ward directed the CDC Division of Viral Hepatitis developing policies for hepatitis A and hepatitis B vaccination and hepatitis B and hepatitis C.

Dr. Bilal Hameed is the Professor of Medicine and the Ambutatory Chair of Hepatology at the University of California Medical Center, San Francisco. He is the Director of the Fatty Liver Clinic at UCSF. <br><br>Dr. Hameed's research program is focused on several critical areas within hepatology, including nonalcoholic steatohepatitis (NASH), post-transplant NASH and novel drug therapies for NASH.

Professor Diana Alcantara-Payawal currently serves as Professor II at Fatima University Medical Center and Chair of the Department of Internal Medicine at Fatima University Medical Center–Valenzuela. She also chairs the Liver Committee under the Section of Gastroenterology at Cardinal Santos Medical Center, where she likewise leads the Committee on Continuing Medical Education.<br><br>Prof. Payawal is internationally recognized for her leadership in global medical organizations.

Dr Giada Sebastiani is a Professor of Medicine and Clinician Scientist at the McGill University Health Centre. Her clinical and research expertise focuses on metabolic dysfunction-associated steatotic liver disease (MASLD) and non-invasive diagnostics in liver disease, with a strong emphasis on vulnerable and underserved populations. She leads a nationally-funded research program, integrating epidemiology, patient-centered strategies, and policy translation. Dr Sebastiani is the President of the Canadian Association for the Study of the Liver, and co-founder of the Canadian MASLD Network.

Shari Rogal is a transplant hepatologist and co-Director of the Dissemination and Implementation Science Core for the VA's Center for Health Equity Research and Promotion. She is an Associate Professor of Medicine, Surgery, and Clinical and Translational Science at the University of Pittsburgh where her research focuses on using precision implementation to improve the equity and quality of care for complex patient populations.

Dr. Michael Li is a transplant hepatologist and gastroenterologist who specializes in caring for patients with cirrhosis, autoimmune liver disease, and liver cancer.<br><br>Dr. Li's research focuses on the relationship between the immune system and liver disease. This includes autoimmune diseases like primary sclerosing cholangitis as well as the use of immunotherapy to treat liver cancer. He seeks to perform meaningful clinical and translational research to achieve a better understanding of immune-mediated liver diseases.<br><br>Dr.

Dr. Sterling received his BS in Chemistry and Natural Science from Muhlenberg College in Allentown Pa in 1982, a Master's in Biochemistry from the University of Texas in Austin in 1984, a MD from Jefferson Medical College in Philadelphia in 1988 and a Master's in Biostatistics and Clinic Research from VCU in 2007. He completed his residency in Internal Medicine in 1991 and Fellowship in Gastroenterology and Transplant Hepatology from VCU in 1994.

Terry Yip is an Associate Professor in the Department of Medicine and Therapeutics and Co-Director (Data Science) of the Medical Data Analytics Centre at The Chinese University of Hong Kong. His research focuses on chronic hepatitis B and MASLD. He is devoted to real-world big data research to understand the epidemiology, natural history, assessment, treatment, and clinical outcome prediction of chronic hepatitis B and MASLD through rigorous statistical analyses and cutting-edge data analytics.